Oncosil Medical Ltd has released a press release.
Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- Ethics Committee Approves PANCOSIL Clinical Trial
- First patient treatment in Italy
- First patient enrolled in the TRIPP-FFX Clinical Study
- OncoSil to streamline operating structure
- First year anniversary of the OSPREY post-marketing registry
Later from OncoSil Medical
- OncoSil onboards first patient in PANCOSIL Clinical Trial
- First two commercial patient treatments in Greece
- OncoSil receives $1.1m R&D tax incentive
- 84 German hospitals can negotiate fee for Oncosil device
- Placement and Entitlement Offer to raise up to $7.1 million
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical